2--hydroxychalcone and Parkinson-Disease

2--hydroxychalcone has been researched along with Parkinson-Disease* in 1 studies

Other Studies

1 other study(ies) available for 2--hydroxychalcone and Parkinson-Disease

ArticleYear
Multitarget 2'-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities.
    Neuropharmacology, 2021, 12-15, Volume: 201

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Anxiety Agents; Binding Sites; Brain; Chalcones; Cholinesterases; In Vitro Techniques; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Rats, Wistar; Receptors, GABA-A; Synaptic Transmission

2021